Key facts
- FA Bio’s last known valuation is $15.8M (Dec 2023).
- It has raised $63.9M; the latest was Later Stage VC ($53.3M) in Apr 2026.
- Notable investors include Plug and Play Tech Center, UK Research and Innovation, Government of UK, Imperial Enterprise Lab, Accelerate Cambridge — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for FA Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for FA Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FA Bio
Operator of a sustainable agriculture company intended to reduce agriculture's environmental impact. The company focuses on discovering and developing microbial biofungicides and biofertilizers targeting microbial sampling strategy and helping to collect data and microbial isolates from agricultural fields to build a database of the soil microbial community with the potential to become microbial products that can replace or enhance the activity of agrochemical inputs, enabling the agricultural market to increase productivity and reduce harmful chemicals and improve sustainability.
- Sector
- Materials and Resources
- HQ
- Harpenden, United Kingdom
- Founded
- 2015
- Employees
- 22
- Website
- fa-bio.net/
- Ownership
- Privately Held (backing)
FA Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FA Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FA Bio in its N-PORT filings yet. We sweep new filings monthly.